Excellence in Teaching Award
Recognizes individuals deeply committed to the profession whose work and accomplishments set a standard of excellence. This award recognizes the importance of teaching as an integral part of women’s cancer care and the lasting impact of educators to shape and inspire future generations of clinicians and researchers.
Andreas Obermair, MD, CGO
Professor Obermair is being honored with the IGCS Excellence in Teaching Award for his lifelong commitment to improve the care of women affected by gynecological cancer through investigation, collaboration, and teaching. In 2008 he founded SurgicalPerformance, which enables surgeons of all specialties to learn about their very own surgical outcomes, including patient-reported outcomes. His research and commitment to education and teaching has gained international recognition for transforming treatment protocols and standards of care and he has developed educational resources for both healthcare professionals and patients.
About Dr. Obermair
Andreas Obermair is a gynaecological oncologist based in Brisbane, Australia.
Andreas obtained his MD at the University of Vienna in 1990 and was awarded his specialist degree in Austria in 1999. He obtained his Fellowship from the Royal Australian and New Zealand College of Obstetrics and Gynaecology in 2002, the same year he completed his gynaecological oncology training.
Andreas established the Queensland Centre for Gynaecological Cancer Research based at The University of Queensland, where he holds a Professorial appointment. Together with 10 other gynaecological oncologists, he leads internationally recognized research into more effective and less invasive treatments for gynaecological cancer. He was the PI of the LACE trial, which helped transform treatment of endometrial cancer from open to minimally invasive surgery. He is the Co-PI of the LACC Trial, which transformed the surgical standard of care from minimally invasive to open surgery in an instant. He is also the PI of the feMMe trial, which provides evidence of the effectiveness of intrauterine levonorgestrel for young and/or frail endometrial cancer patients who can be spared a hysterectomy.
Previously, Andreas served on the IGCS council and on the board of the Australia and New Zealand Gynaecological Oncology Group (ANZGOG). He is the co-founder of the Cherish Women’s Cancer Foundation, which raises funds to enable gynaecological cancer research.
In 2008 he founded SurgicalPerformance, which enables surgeons of all specialties to learn about their very own surgical outcomes, including patient-reported outcomes. SurgicalPerformance is taken up by hundreds of users worldwide to enhance their knowledge about their own surgical practice.